Yeast .beta.-d-glucan clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses yeast .beta.-d-glucan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- Beta glucan
- 1
Studies by the year they started
3 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2016 | 1 |
Who runs them
Industry 2 · Other 1
Studies
Open first, then newest update. How each study uses yeast .beta.-d-glucan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser AblationCompletedPhase 1/2TR TherapeuticsNCT00656474Written as GLYC-101 gel (1.0 %)
- Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser AblationCompletedPhase 2TR TherapeuticsNCT00792688Written as GLYC-101 Gel (0.1%)
- Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency UlcersActive, not recruitingPhase 2SerenaGroup, Inc.NCT03154619Written as 0.1% TR 987
Codes
What other systems call yeast .beta.-d-glucan · ClinicalTrials.gg INT014795
- RxNorm 2563625One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 2563625 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.